SG10201810255YA - Chitin-glucan complex, its preparation, and uses - Google Patents

Chitin-glucan complex, its preparation, and uses

Info

Publication number
SG10201810255YA
SG10201810255YA SG10201810255YA SG10201810255YA SG10201810255YA SG 10201810255Y A SG10201810255Y A SG 10201810255YA SG 10201810255Y A SG10201810255Y A SG 10201810255YA SG 10201810255Y A SG10201810255Y A SG 10201810255YA SG 10201810255Y A SG10201810255Y A SG 10201810255YA
Authority
SG
Singapore
Prior art keywords
chitin
preparation
glucan complex
biocomposite powder
glucan
Prior art date
Application number
SG10201810255YA
Inventor
De Freitas Maria Andrade
Silva Cruz Fernando Da
Carvalho Fernandes De Miranda Reis Maria D'ascensâo
Silva Farinha Inès Da
Original Assignee
Pharma73 S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma73 S A filed Critical Pharma73 S A
Publication of SG10201810255YA publication Critical patent/SG10201810255YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CHITIN-GLUCAN COMPLEX, ITS PREPARATION, AND USES A biocomposite powder comprising 20-95% (w/w) chitin-glucan complex (CGC), and up to 50% (w/w) mannose-containing polysaccharides, wherein the biocomposite powder has a bulk density of 0.5 to 1.0 g/cm 3 , and wherein greater than 60% (w/w) of the particles of the biocomposite powder have a size below 212 pm. No suitable figure to accompany abstract
SG10201810255YA 2014-05-21 2015-05-19 Chitin-glucan complex, its preparation, and uses SG10201810255YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462001306P 2014-05-21 2014-05-21

Publications (1)

Publication Number Publication Date
SG10201810255YA true SG10201810255YA (en) 2018-12-28

Family

ID=53524915

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201609605RA SG11201609605RA (en) 2014-05-21 2015-05-19 Chitin-glucan complex, its preparation, and uses
SG10201810255YA SG10201810255YA (en) 2014-05-21 2015-05-19 Chitin-glucan complex, its preparation, and uses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201609605RA SG11201609605RA (en) 2014-05-21 2015-05-19 Chitin-glucan complex, its preparation, and uses

Country Status (11)

Country Link
US (1) US11077060B2 (en)
EP (1) EP3145494A1 (en)
CN (1) CN106572959A (en)
AU (2) AU2015263025A1 (en)
BR (1) BR112016027254A8 (en)
CA (1) CA2949752A1 (en)
IL (1) IL249073B (en)
MA (1) MA40022A (en)
MX (1) MX2016015197A (en)
SG (2) SG11201609605RA (en)
WO (1) WO2015177622A1 (en)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2118370A (en) 1932-01-30 1938-05-24 Industrikemiska Ab Method of treating fermenting liquids
US4992540A (en) 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
GB2259709A (en) 1991-09-19 1993-03-24 British Textile Tech Production of chitin/chitosan
US5169638A (en) 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5654007A (en) 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US6210686B1 (en) 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
BE1014638A6 (en) 2002-02-12 2004-02-03 Univ Liege Method of preparation of derivatives of cell wall from biomass.
US20070299034A1 (en) * 2002-02-12 2007-12-27 Marie-France Versali Cell wall derivatives, their preparation process, and use thereof
US20050042735A1 (en) 2003-04-11 2005-02-24 Ming-De Deng Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
US7608270B2 (en) * 2003-06-27 2009-10-27 University Of Hull Dosage form
BRPI0611535B1 (en) 2005-05-05 2021-11-30 Sensient Flavors Inc METHOD FOR PROCESSING YEAST CELLS TO PRODUCE BETA-GLUCANS AND MANANAS
FR2908771B1 (en) * 2006-11-20 2011-07-29 Kitozyme Sa CHITINE-GLUCAN OF FINE EXTRACT FINE GRANULOMETRY
PT103714B (en) 2007-04-11 2020-07-28 73100 - Setenta E Três Mil E Cem, Lda. PROCESS FOR OBTAINING A GALACTOSE-BASED POLYMER
PT104149B (en) * 2008-07-30 2020-05-08 73100 - Setenta E Três Mil E Cem, Lda. CO-PRODUCTION PROCESS OF CHITIN, ITS DERIVATIVES AND POLYMERS CONTAINING GLUCOSE, MANNOSIS AND / OR GALACTOSE, BY CULTIVATING THE PICHIA PASTORIS YEAST
EP2221358A1 (en) 2009-02-24 2010-08-25 Universität für Bodenkultur Wien Biotin-prototrophic yeasts
US8748123B2 (en) 2009-12-15 2014-06-10 73100-Setenta e Tres Mil e Cem, Lda. Fucose-containing bacterial biopolymer
MX360025B (en) * 2012-03-23 2018-10-18 Pharma73 S A Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient.

Also Published As

Publication number Publication date
AU2015263025A1 (en) 2017-01-12
CN106572959A (en) 2017-04-19
IL249073B (en) 2021-04-29
WO2015177622A1 (en) 2015-11-26
BR112016027254A8 (en) 2021-06-29
MA40022A (en) 2015-11-26
BR112016027254A2 (en) 2017-08-15
MX2016015197A (en) 2017-06-29
IL249073A0 (en) 2017-01-31
SG11201609605RA (en) 2016-12-29
EP3145494A1 (en) 2017-03-29
CA2949752A1 (en) 2015-11-26
US11077060B2 (en) 2021-08-03
AU2020210208A1 (en) 2020-08-20
US20170079917A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
MX2021003256A (en) Abrasive article including shaped abrasive particles.
CN106687083A8 (en) Absorbent article
AU366476S (en) Bottle
SG10202010599TA (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
MX2016013376A (en) Low pressure sintering powder.
MY169154A (en) Tobacco material, tobacco product to which tobacco material is added, and method for producing tobacco material
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX2016003711A (en) Particles.
MA39883A (en) Individualised inorganic particles
MX2015001526A (en) Synthetic proppants and monodispersed proppants and methods of making the same.
MX2015009106A (en) Solid solution compositions and use in severe pain.
MX2015015923A (en) Encapsulates.
MX2015013014A (en) Microalgal flour granules and process for preparation thereof.
AU356378S (en) Bottle
GEP20207114B (en) A dietary fibre composition
EP3202833A4 (en) Expanded article, and expanded particles used to produce same
GB2540825A (en) Improved suspension of proppant particles in hydraulic fracturing fluid
MX2016006916A (en) Pharmaceutical composition, comprising phosphate binder particles.
PH12015502832B1 (en) Processes for producing dark red and dark brown natural cocoa
GB201210060D0 (en) Composition
MX2016016613A (en) Composition in the form of compacted particles and use thereof.
MY174912A (en) Non-replicating virus-derived particles and uses thereof
MX2015014382A (en) Resin composition and molded article.
SG10201810255YA (en) Chitin-glucan complex, its preparation, and uses
MX2018003960A (en) Composition for dust particle reduction.